诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVO 诺和诺德

交易中 07-16 15:56:56 EDT

51.44

+0.88

+1.73%

最高51.77	最低50.60	成交量826.79万
今开50.91	昨收50.56	日振幅2.31%
总市值2,283亿	流通市值1,640亿	总股本44.39亿
成交额4.25亿	换手率0.26%	流通股本31.88亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVO","market":"US","secType":"STK","nameCN":"诺和诺德","latestPrice":51.435,"timestamp":1784231816613,"preClose":50.56,"halted":0,"volume":8267897,"delay":0,"changeRate":0.017306170886075948,"floatShares":3187922885,"shares":4439052849,"eps":4.228648,"marketStatus":"交易中","change":0.875,"latestTime":"07-16 15:56:56 EDT","open":50.91,"high":51.77,"low":50.6001,"amount":425184069.135991,"amplitude":0.023139,"askPrice":51.44,"askSize":451,"bidPrice":51.43,"bidSize":977,"shortable":3,"etf":0,"ttmEps":4.228648,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784232000000},"marketStatusCode":2,"adr":1,"adrRate":1,"listingDate":363499200000,"exchange":"NYSE","adjPreClose":50.56,"dividendRate":0.033478,"preHourTrading":{"tag":"盘前","latestPrice":50.93,"preClose":50.56,"latestTime":"09:29 EDT","volume":236005,"amount":12040049.9604,"timestamp":1784208599999,"change":0.37,"changeRate":0.007318,"amplitude":0.019185},"postHourTrading":{"tag":"盘后","latestPrice":50.6596,"preClose":50.56,"latestTime":"19:59 EDT","volume":154918,"amount":7827010.6038,"timestamp":1784159998958,"change":0.0996,"changeRate":0.00197,"amplitude":0.005324},"volumeRatio":1.15289,"optionData":{"bulkOrders":[{"symbol":"NVO","call":false,"expireDate":1792123200000,"strike":"45.0","timestamp":1784228919715,"price":1.59,"volume":1500,"amount":238500,"type":"+"}]},"impliedVol":0.4974,"impliedVolPercentile":0.4781},"requestUrl":"/m/hq/s/NVO","defaultTab":"news","newsList":[{"id":"2651411341","title":"诺和诺德口服减重药物获欧盟委员会批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2651411341","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651411341?lang=zh_cn&edition=full","pubTime":"2026-07-16 15:01","pubTimestamp":1784185275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["THNR","IE00BZ1G4Q59.USD","BK4007","IE00BKVL7J92.USD","LU1093756325.SGD","BK4532","PPH","LU1093756168.USD","NVO","NVOX","BK4588","LU0154236417.USD","BK4599","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651629864","title":"市场消息：诺和诺德Wegovy口服片获欧盟批准为首个口服GLP-1减肥药。","url":"https://stock-news.laohu8.com/highlight/detail?id=2651629864","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651629864?lang=zh_cn&edition=full","pubTime":"2026-07-15 23:51","pubTimestamp":1784130670,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","LU0154236417.USD","IE00BZ1G4Q59.USD","NVOH","BK4599","IE00BKVL7J92.USD","PPH","LU1093756168.USD","LU1093756325.SGD","BK4007","BK4532","NVO","BK4588","NVOX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125700765","title":"异动解读｜诺和诺德盘中上涨3.07%，口服减重药处方量以89%份额碾压礼来","url":"https://stock-news.laohu8.com/highlight/detail?id=1125700765","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125700765?lang=zh_cn&edition=full","pubTime":"2026-07-15 22:28","pubTimestamp":1784125728,"startTime":"0","endTime":"0","summary":"7月15日，诺和诺德盘中上涨3.07%，报50.57美元/股，成交额1.14亿美元。消息面上，IQVIA最新处方数据显示，截至7月3日当周，Wegovy口服制剂在美国的单周处方量约15.31万张，礼来Foundayo仅1.96万张，诺和诺德拿下口服减重药品类89%的处方量，礼来仅占11%。Wegovy口服制剂上市第13周单周处方量便突破10.5万张，规模为同期Foundayo的5倍以上，先发优势显著。机构随即下调礼来Foundayo销售额预期，进一步确认诺和诺德在口服减重赛道的领先地位。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"异动解读｜诺和诺德盘中上涨3.07%，口服减重药处方量以89%份额碾压礼来","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651469666","title":"【券商聚焦】礼来口服减重药上市三月处方量大幅落后诺和诺德 机构下调Foundayo销售额预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2651469666","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651469666?lang=zh_cn&edition=full","pubTime":"2026-07-15 21:50","pubTimestamp":1784123427,"startTime":"0","endTime":"0","summary":"IQVIA 截至 7 月 3 日当周数据显示，当期 Wegovy 口服制剂美国处方量约 15.31 万张，Foundayo 仅 1.96 万张，诺和诺德拿下该品类 89% 处方量，礼来占比仅 11%。诺和诺德年内先行推出口服司美格鲁肽 Wegovy，礼来 4 月推出 Foundayo。依托先发优势，Wegovy 口服制剂上市第 13 周单周处方量便超 10.5 万张，规模为同期 Foundayo 的 5 倍以上。礼来发言人表示，伴随医生、药房及患者认知提升，Foundayo 销售势能有望逐步释放。","market":"other","thumbnail":"https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/OTU2NGE4NGJmZTIzZDc2N2YxYmJkM2MyMjUzODQzOTQ1NzY=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"299f0a9977df499f8ead781071e5e5e7","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302610","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRX11.SGD","LU2471134952.CNY","LU2750360997.AUD","LU0316494557.USD","BK4007","IE00B7KXQ091.USD","MEDX","IE00BFSS7M15.SGD","LU2324357040.USD","SG9999017495.SGD","IE00B2B36J28.USD","LU1035775433.USD","LU0353189763.USD","LU2237443978.SGD","LU0174119429.USD","LU2265009873.SGD","LU0320765992.SGD","LU0238689110.USD","LU1057294990.SGD","LU1989771016.USD","SGXZ99366536.SGD","LU0823434583.USD","LU1366192091.USD","LU2236285917.USD","LU0320765059.SGD","LU2471134796.USD","LU1069344957.HKD","LU2237443622.USD","LU2213496289.HKD","LU2168564065.EUR","LU2462591350.SGD","SG9999014914.USD","BK4534","LU0079474960.USD","SGXZ81514606.USD","LU1712237335.SGD","IE00BKPKM429.USD","JDOC","LU0106261372.USD","LU1551013342.USD","LU2756315664.SGD","LU2237443382.USD","LU0417517546.SGD","IE0002141913.USD","BK4532","LU2361045086.USD","SG9999015986.USD","BK4581","IE00B1XK9C88.USD","ILDR","LU2468319806.SGD","LU0820561909.HKD","IE00BKVL7J92.USD","LU2106854487.HKD","LU2456880835.USD","LU1323610961.USD","THNR","IE00B1BXHZ80.USD","LU0114720955.EUR","LU0964807845.USD","LU2552382058.USD","LU0820561818.USD","LU2089284900.SGD","IE00BWXC8680.SGD","LU2063271972.USD","LU2361044949.HKD","LU2491049909.HKD","LU0456855351.SGD","LU2461242641.AUD","LU2746668974.SGD","LU2360106947.USD","LU0820562030.AUD","IE0004445239.USD","LU2750360641.GBP","WDNA","LU0289739699.SGD","LU0154236417.USD","LU0354030511.USD","CANC","LU0210536198.USD","LLII","LU2471134879.HKD","LU0266013472.USD","BK4585","LU0672654240.SGD","LU1868836757.USD","LU0471298777.SGD","ELIL","SGXZ57979304.SGD","IE0009355771.USD","LU0203202063.USD","LU0708995401.HKD","LU0432979614.USD","LU2108987350.USD","LU0823416689.USD","LU1868837136.USD","LU1868837300.USD","LU1291159041.SGD","LU2552382215.SGD","SG9999014898.SGD","IE00BFSS8Q28.SGD","LU2552382132.HKD","FTXH","LU1804176565.USD","LU1629891620.HKD","LU1064131342.USD","LU0345770308.USD","LU2756315318.SGD","LU1814569148.SGD","VHT","RXL","LU2462157665.USD","IE00BFTCPJ56.SGD","LU1720051108.HKD","LU0882574139.USD","LU0256863902.USD","LU0823434740.USD","LU2168564495.EUR","LU2361044865.SGD","SG9999018865.SGD","IE00B4JS1V06.HKD","PJP","LU0786609619.USD","IE00BJLML261.HKD","IE00BJT1NW94.SGD","IXJ","LU1145028129.USD","LU2023251221.USD","LU2896262040.SGD","PPH","SG9999001176.SGD","LU1280957306.USD","IE00B4R5TH58.HKD","LU0225283273.USD","LU2087625088.SGD","LU0683600562.USD","LU2028103732.USD","LU0158827781.USD","LU0640476718.USD","IE0001KFT4U8.USD","LU1023059063.AUD","IYH","LU2023250330.USD","LU2168564222.USD","LU0354030438.USD","LU0006306889.USD","LU2211815571.USD","LU2237443465.HKD","LU2168564149.EUR","AGNG","LU1548497426.USD","NVOH","LU0058720904.USD","LLY","LU0122379950.USD","LU2491050154.USD","LU0096364046.USD","LU2271345857.HKD","CURE","SGXZ31699556.SGD","LU0158827948.USD","LU2237443549.SGD","LU0689472784.USD","LU2417539215.USD","LU0203201768.USD","GB00BDT5M118.USD","LU2111349929.HKD","IE0005OL40V9.USD","LU2168563687.JPY","LU2237443895.HKD","LU2471134523.USD","NVOX","BK4516","LU0234572021.USD","LU0889565916.HKD","LU1061106388.HKD","IE00BZ1G4Q59.USD","IE00BN29S564.USD","OZEM","LU2237438978.USD","LU1974910355.USD","LU1093756168.USD","BK4533","LU1127390331.HKD","LU2491050071.SGD","LU0094547139.USD","LU0943347566.SGD","SGXZ51526630.SGD","SG9999015945.SGD","BK4588","LU0345770993.USD","LU1093756325.SGD","LU1868836914.USD","LU0061475181.USD","LU1988902786.USD","LU2023250504.SGD","LU1983299246.USD","LU0385154629.USD","LU2112291526.USD","LU2357305700.SGD","LU0133085943.USD","LU0466842654.USD","LU2746668461.USD","SG9999014880.SGD","LU1623119135.USD","IE00BK4W5M84.HKD","LU1267930730.SGD","LU1868836591.USD","BK4599","GDOC","XLV","IE00B775H168.HKD","LU0882574055.USD","LU1551013425.SGD","SG9999015978.USD","SG9999001176.USD","IE00BKDWB100.SGD","IE00BJJMRY28.SGD","FHLC","IHE","LU2089283258.USD","LLYX","IE00BJJMRZ35.SGD","LU2089984988.USD","MEDI","LU0109394709.USD","LU2264538146.SGD","NVO","SG9999018857.SGD","LU0471298694.HKD","LU1232071149.USD","LU0097036916.USD","IE0004445015.USD","LU0109391861.USD","IE00BK4W5L77.USD","SG9999015952.SGD","LU0353189680.USD","LU0256863811.USD","LU2602419157.SGD","SG9999014906.USD","HRTS","LLYZ","LU1917777945.USD","SG9999013999.USD","LU0198837287.USD","LU0787776722.HKD","LU1720051017.SGD","ELIS","LU0323591593.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651480626","title":"减肥药大战：诺和诺德口服药遥遥领先礼来","url":"https://stock-news.laohu8.com/highlight/detail?id=2651480626","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651480626?lang=zh_cn&edition=full","pubTime":"2026-07-15 08:45","pubTimestamp":1784076344,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00B1BXHZ80.USD","LU0289739699.SGD","LU0787776722.HKD","LLYZ","LU2237443978.SGD","LU0385154629.USD","LU0154236417.USD","LU0097036916.USD","LU1093756168.USD","LU2271345857.HKD","LU0094547139.USD","LU2750360641.GBP","LU2471134952.CNY","LU0432979614.USD","LU0198837287.USD","LU2108987350.USD","LU2361044949.HKD","LU1057294990.SGD","LU0823416689.USD","IE00BJJMRZ35.SGD","LU1145028129.USD","LU2756315318.SGD","LU1064131342.USD","LU1983299246.USD","HRTS","LU0210536198.USD","SGXZ31699556.SGD","LU0238689110.USD","BK4533","LU0158827781.USD","LU2089984988.USD","LU1712237335.SGD","LU0466842654.USD","LU2237443895.HKD","LU1323610961.USD","LU2491050071.SGD","IE00BK4W5M84.HKD","LU2462157665.USD","LU0006306889.USD","LU2357305700.SGD","SG9999015978.USD","XLV","LU2089284900.SGD","LU2471134796.USD","LU2552382058.USD","LU2461242641.AUD","LU0266013472.USD","SGXZ57979304.SGD","LU0109391861.USD","LU2213496289.HKD","LU1551013425.SGD","LU0417517546.SGD","ELIS","LU1069344957.HKD","LU1868836591.USD","GDOC","LU0964807845.USD","LU1804176565.USD","LU2471134879.HKD","IE0004445239.USD","LU0106261372.USD","LU0203201768.USD","LU2168564065.EUR","LU2265009873.SGD","CANC","LU0061475181.USD","LU0823434740.USD","LU2023251221.USD","LU2236285917.USD","IE0001KFT4U8.USD","SGXZ51526630.SGD","LU2211815571.USD","LU0079474960.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU2237443465.HKD","LU2023250504.SGD","IE00B4JS1V06.HKD","LU0353189763.USD","LU1868837300.USD","LU0345770993.USD","SGXZ81514606.USD","JDOC","LU2750360997.AUD","LU0109394709.USD","IHE","LU1061106388.HKD","IE00BFSS7M15.SGD","LU2468319806.SGD","LU2361044865.SGD","SG9999015986.USD","LU0456855351.SGD","RXL","LU0689472784.USD","IE00BJJMRY28.SGD","LU1232071149.USD","SG9999013999.USD","LU0158827948.USD","LU2023250330.USD","IE00BJJMRX11.SGD","SG9999014914.USD","IE00B1XK9C88.USD","LU0256863902.USD","LU2237443622.USD","LLY","LLYX","LU1814569148.SGD","LU0203202063.USD","IE00BKPKM429.USD","LU0256863811.USD","LU2361045086.USD","BK4516","LU0122379950.USD","IE00BJLML261.HKD","LU1988902786.USD","LU2106854487.HKD","SGXZ99366536.SGD","LU0471298777.SGD","LU1868837136.USD","FTXH","IE00BZ1G4Q59.USD","LU0823434583.USD","LU0345770308.USD","LU0320765992.SGD","LU0820562030.AUD","LU1548497426.USD","BK4007","LU1035775433.USD","IE00BK4W5L77.USD","LU2168564495.EUR","LU1974910355.USD","AGNG","IE00B7KXQ091.USD","LU0058720904.USD","LU1917777945.USD","ELIL","IE0005OL40V9.USD","LU0225283273.USD","LU0354030511.USD","LU1127390331.HKD","LU1868836914.USD","LU2111349929.HKD","IE00BFTCPJ56.SGD","SG9999015945.SGD","LLII","IE00B775H168.HKD","NVOH","SG9999017495.SGD","LU0672654240.SGD","LU0882574055.USD","LU1267930730.SGD","LU0353189680.USD","WDNA","LU0320765059.SGD","PPH","LU2324357040.USD","LU1280957306.USD","LU1551013342.USD","LU2168563687.JPY","IE00BKDWB100.SGD","LU0708995401.HKD","LU1093756325.SGD","LU0820561909.HKD","OZEM","LU0786609619.USD","LU0323591593.USD","LU2417539215.USD","LU2237443549.SGD","LU0943347566.SGD","LU2746668974.SGD","LU2746668461.USD","SG9999014898.SGD","BK4588","LU0471298694.HKD","LU0114720955.EUR","LU0234572021.USD","LU2491050154.USD","SG9999014906.USD","BK4585","SG9999001176.USD","LU0096364046.USD","LU1720051017.SGD","LU2491049909.HKD","LU1629891620.HKD","LU2087625088.SGD","LU2264538146.SGD","LU1023059063.AUD","NVO","NVOX","IE00BN29S564.USD","LU2360106947.USD","LU2602419157.SGD","LU0640476718.USD","LU0882574139.USD","LU2896262040.SGD","LU2456880835.USD","LU2112291526.USD","LU1720051108.HKD","LU1989771016.USD","LU1868836757.USD","LU2471134523.USD","LU2552382215.SGD","LU0133085943.USD","MEDX","SG9999018857.SGD","IE0004445015.USD","LU1623119135.USD","IE0009355771.USD","LU0316494557.USD","LU2063271972.USD","LU2168564222.USD","LU0683600562.USD","LU2168564149.EUR","LU0820561818.USD","BK4534","IXJ","IE00BWXC8680.SGD","LU2756315664.SGD","LU1366192091.USD","IE00B2B36J28.USD","LU0354030438.USD","SG9999014880.SGD","SG9999018865.SGD","LU1291159041.SGD","BK4581","BK4532","LU2237443382.USD","LU2028103732.USD","GB00BDT5M118.USD","LU2552382132.HKD","IE0002141913.USD","IE00BJT1NW94.SGD","SG9999015952.SGD","LU2089283258.USD","IE00BFSS8Q28.SGD","IE00B4R5TH58.HKD","LU2237438978.USD","VHT","ILDR","SG9999001176.SGD","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650994978","title":"诺和诺德印度高管：产品将于下周推出。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650994978","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650994978?lang=zh_cn&edition=full","pubTime":"2026-07-09 14:50","pubTimestamp":1783579852,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["OZEM","BK4585","IE00BZ1G4Q59.USD","BK4588","NVO","NVOX","THNR","NVOH","BK4599","LU0154236417.USD","LU1093756325.SGD","PPH","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650194633","title":"诺和诺德中国称旗下糖尿病治疗创新药司美格鲁肽注射液等纳入新版国家基本药物目录。","url":"https://stock-news.laohu8.com/highlight/detail?id=2650194633","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650194633?lang=zh_cn&edition=full","pubTime":"2026-07-09 13:48","pubTimestamp":1783576102,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1093756325.SGD","NVOX","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","BK4585","PPH","OZEM","BK4599","BK4588","NVO","NVOH","THNR","LU0154236417.USD","LU1093756168.USD","BK4007","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650118199","title":"诺和诺德：从“销往中国”到“造福全球”","url":"https://stock-news.laohu8.com/highlight/detail?id=2650118199","media":"经济日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650118199?lang=zh_cn&edition=full","pubTime":"2026-07-09 06:06","pubTimestamp":1783548409,"startTime":"0","endTime":"0","summary":"前不久，总部位于丹麦的全球性生物制药公司诺和诺德宣布，“中国同创”项目全球同步研发的首个基础胰岛素周制剂产品在中国上市；其位于天津的战略生产基地追加投资2亿元人民币，用于提升相关生产能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202607093798863797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["OZEM","BK4585","BK4588","THNR","BK4532","LU1093756168.USD","LU1093756325.SGD","NVOX","BK4007","PPH","IE00BKVL7J92.USD","NVOH","BK4599","IE00BZ1G4Q59.USD","LU0154236417.USD","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649999426","title":"诺和诺德CEO：将推进中国业务和全球战略深度整合","url":"https://stock-news.laohu8.com/highlight/detail?id=2649999426","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649999426?lang=zh_cn&edition=full","pubTime":"2026-07-08 21:34","pubTimestamp":1783517673,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BZ1G4Q59.USD","LU1093756168.USD","NVOX","BK4588","NVO","PPH","IE00BKVL7J92.USD","BK4599","BK4532","NVOH","LU1093756325.SGD","BK4007","OZEM","LU0154236417.USD","BK4585","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649441963","title":"Vivani Medical 与 Novo Nordisk 达成协议，评估用于长期体重管理的微型超长效司美格鲁肽植入剂 NPM-139","url":"https://stock-news.laohu8.com/highlight/detail?id=2649441963","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649441963?lang=zh_cn&edition=full","pubTime":"2026-07-08 11:12","pubTimestamp":1783480320,"startTime":"0","endTime":"0","summary":"Novo Nordisk 将对 Vivani 制备的司美格鲁肽植入剂进行非独家内部评估加利福尼亚州阿拉米达, July  08, 2026   -- Vivani Medical, Inc. 是一家开发新型超长效药物植入剂的创新型生物制药公司，今日宣布与 Novo Nordisk 签署一项新协议，授权 Novo Nordisk 评估旗下司美格鲁肽药物植入剂 NPM-139。依托 Vivani 的 NanoPortal 平台技术，正在开发 NPM-139 用于长期体重管理。此外，Vivani 预计将于 2026 年中期启动一项评估 NPM-139 司美格鲁肽植入剂的随机首次人体 1 期临床研究，并以 Wegovy 注射剂作为活性对照。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/07/08/3323795/0/zh-hans/Vivani-Medical-%E4%B8%8E-Novo-Nordisk-%E8%BE%BE%E6%88%90%E5%8D%8F%E8%AE%AE-%E8%AF%84%E4%BC%B0%E7%94%A8%E4%BA%8E%E9%95%BF%E6%9C%9F%E4%BD%93%E9%87%8D%E7%AE%A1%E7%90%86%E7%9A%84%E5%BE%AE%E5%9E%8B%E8%B6%85%E9%95%BF%E6%95%88%E5%8F%B8%E7%BE%8E%E6%A0%BC%E9%B2%81%E8%82%BD%E6%A4%8D%E5%85%A5%E5%89%82-NPM-139.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OZEM","BK4007","THNR","VANI","BK4585","NVOH","IE00BKVL7J92.USD","BK4082","IE00BZ1G4Q59.USD","PPH","NVO","LU1093756168.USD","LU0154236417.USD","NVOX","BK4599","BK4588","LU1093756325.SGD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159320796","title":"异动解读｜诺和诺德盘中下跌3.05%，报48.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1159320796","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159320796?lang=zh_cn&edition=full","pubTime":"2026-07-06 21:49","pubTimestamp":1783345799,"startTime":"0","endTime":"0","summary":"7月6日，诺和诺德盘中下跌3.05%，报48.70美元/股，成交额8019.73万美元。诺和诺德所在的制药行业中，整体表现疲弱，个股中，礼来跌2.0%，强生跌2.45%，辉瑞跌2.24%，默沙东跌1.94%，阿斯利康跌4.11%。Novo Nordisk A/S是一家全球性医疗保健公司，也是肥胖和糖尿病护理领域的世界领先企业，总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649643191","title":"汇丰将诺和诺德目标价从280丹麦克朗上调至300丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2649643191","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649643191?lang=zh_cn&edition=full","pubTime":"2026-07-06 13:19","pubTimestamp":1783315176,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0496365809.HKD","BK4007","BK4532","LU1093756325.SGD","00005","LU0128525689.USD","LU1093756168.USD","NVO","THNR","BK4599","LU2236285917.USD","IE00BZ1G4Q59.USD","NVOH","PPH","LU1267930227.SGD","LU0976567544.SGD","NVOX","LU0211326755.USD","OZEM","HSBC","BK4207","LU0211326839.USD","LU0052756011.USD","BK4521","HSBH","IE00BKVL7J92.USD","BK4585","LU0154236417.USD","LU0310800965.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648685208","title":"诺和诺德(NVO)涨3.8% 施压供应商争取折扣 削减成本反攻减肥药市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2648685208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648685208?lang=zh_cn&edition=full","pubTime":"2026-07-02 22:24","pubTimestamp":1783002296,"startTime":"0","endTime":"0","summary":"消息面上，丹麦药企诺和诺德发函合作供应商，协商压低采购成本，意图扭转减肥药市场竞争劣势，抢夺礼来  占据的行业龙头地位。诺和诺德表示供应商参与让利并非强制要求，但让利成效将纳入后续合作评估维度。降本举措并非单一动作，今年 9 月诺和诺德推出大规模裁员计划，拟全球裁减 9000 名员工，叠加本次供应链压价，共同组成新任 CEO 主导的全面降本方案，依托压缩开支优化产品定价，争夺减肥药赛道市场份额。","market":"fut","thumbnail":"https://static.szfiu.com/news/20250107/NTE3MzYyMzA2NDI2MjU=.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/NTE3MzYyMzA2NDI2MjU=.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302165","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823416689.USD","SG9999013999.USD","LU2237443465.HKD","SG9999014880.SGD","LU1983299246.USD","LU1267930730.SGD","IE00BJJMRZ35.SGD","LU1720051017.SGD","LU0345770993.USD","SG9999015945.SGD","LU1280957306.USD","IE00BJLML261.HKD","LU2089284900.SGD","BK4007","LU1291159041.SGD","LU0234572021.USD","LU2602419157.SGD","LU0316494557.USD","LU2361044865.SGD","LU1064131342.USD","LU0320765992.SGD","LU0823434740.USD","LU0256863811.USD","LU2746668974.SGD","LU2168564222.USD","LU0158827781.USD","LU2211815571.USD","IE00BFSS8Q28.SGD","LU0354030511.USD","LU0354030438.USD","LU1868836914.USD","LU2491049909.HKD","NVOH","SG9999001176.USD","IE00BKDWB100.SGD","LU2746668461.USD","LU2756315664.SGD","LU2471134952.CNY","LU0133085943.USD","SGXZ81514606.USD","LU1551013342.USD","LU1069344957.HKD","SG9999014906.USD","IE00B4R5TH58.HKD","LU0203202063.USD","LU2168564149.EUR","LU1868836591.USD","GB00BDT5M118.USD","LU2471134796.USD","BK4534","IE00BFSS7M15.SGD","IE00BJT1NW94.SGD","LU2461242641.AUD","LU1035775433.USD","LU0320765059.SGD","IE00BK4W5L77.USD","LU0323591593.USD","LU2417539215.USD","LU0689472784.USD","LU0058720904.USD","LU2357305700.SGD","LU0456855351.SGD","LU2237443622.USD","LU0154236417.USD","LU0417517546.SGD","LU0210536198.USD","LU0640476718.USD","LU2111349929.HKD","SGXZ99366536.SGD","NVOX","LU1988902786.USD","IE00B1XK9C88.USD","LU2087625088.SGD","LU2089984988.USD","LU2552382215.SGD","LU2023250504.SGD","SG9999014914.USD","IE00B775H168.HKD","LU2237438978.USD","LU2236285917.USD","BK4588","LU0385154629.USD","IE00B1BXHZ80.USD","BK4581","LU0353189763.USD","LU2213496289.HKD","LU0158827948.USD","SG9999018857.SGD","LU0256863902.USD","LU1061106388.HKD","LU0289739699.SGD","LU0889565916.HKD","SG9999018865.SGD","SG9999015978.USD","LU0943347566.SGD","LU2324357040.USD","LU0094547139.USD","LU1629891620.HKD","LU2237443382.USD","LU2361045086.USD","IE0004445239.USD","SG9999015986.USD","LU0683600562.USD","LU0882574139.USD","LU0672654240.SGD","LLII","LLYZ","LU1623119135.USD","IE00BJJMRY28.SGD","LU1868837136.USD","LU2361044949.HKD","SG9999015952.SGD","LU0122379950.USD","LU0820561909.HKD","LU2456880835.USD","LLYX","LU2023251221.USD","LU1145028129.USD","LU0432979614.USD","LU1804176565.USD","LU2471134879.HKD","IE00B2B36J28.USD","LU2237443549.SGD","LU2265009873.SGD","IE0001KFT4U8.USD","LU0820562030.AUD","BK4533","LU0203201768.USD","LU1023059063.AUD","LU2750360997.AUD","IE00BZ1G4Q59.USD","LU2896262040.SGD","IE0002141913.USD","IE0004445015.USD","ELIL","LLY","LU1712237335.SGD","LU0225283273.USD","LU0708995401.HKD","LU0238689110.USD","NVO","BK4585","IE00B7KXQ091.USD","LU2552382132.HKD","LU0466842654.USD","LU0114720955.EUR","LU1917777945.USD","LU2237443895.HKD","IE00BN29S564.USD","LU0061475181.USD","IE0009355771.USD","LU1974910355.USD","LU2491050071.SGD","IE00B4JS1V06.HKD","LU2360106947.USD","LU1232071149.USD","LU2108987350.USD","LU0109391861.USD","LU1127390331.HKD","LU2106854487.HKD","BK4599","LU0079474960.USD","LU2552382058.USD","LU1323610961.USD","LU2168564495.EUR","LU2063271972.USD","SGXZ31699556.SGD","LU2112291526.USD","LU0471298694.HKD","IE00BKPKM429.USD","LU1868836757.USD","SG9999017495.SGD","LU0786609619.USD","LU1989771016.USD","IE00BWXC8680.SGD","LU2264538146.SGD","LU0471298777.SGD","SG9999001176.SGD","LU2168564065.EUR","LU2089283258.USD","LU2168563687.JPY","SGXZ51526630.SGD","LU2237443978.SGD","LU2756315318.SGD","LU0198837287.USD","LU0006306889.USD","LU2028103732.USD","LU2462157665.USD","LU1551013425.SGD","IE00BJJMRX11.SGD","LU0097036916.USD","LU0266013472.USD","LU1868837300.USD","BK4516","ELIS","IE00BFTCPJ56.SGD","LU0096364046.USD","LU2471134523.USD","LU2491050154.USD","LU0109394709.USD","LU1093756325.SGD","LU0787776722.HKD","LU0882574055.USD","LU0820561818.USD","LU0106261372.USD","IE00BKVL7J92.USD","LU0964807845.USD","LU2023250330.USD","SGXZ57979304.SGD","LU2468319806.SGD","LU1548497426.USD","BK4532","LU2750360641.GBP","LU0353189680.USD","SG9999014898.SGD","LU1814569148.SGD","LU1093756168.USD","LU2271345857.HKD","LU1057294990.SGD","IE00BK4W5M84.HKD","LU1720051108.HKD","LU1366192091.USD","LU0823434583.USD","IE0005OL40V9.USD","LU0345770308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176916059","title":"异动解读｜诺和诺德盘中上涨3.09%，Medicare覆盖落地叠加供应链降本举措提振","url":"https://stock-news.laohu8.com/highlight/detail?id=1176916059","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176916059?lang=zh_cn&edition=full","pubTime":"2026-07-02 21:55","pubTimestamp":1783000532,"startTime":"0","endTime":"0","summary":"7月2日，诺和诺德盘中上涨3.09%，报50.355美元/股，成交额1.11亿美元。消息面上，美国联邦医疗保险自7月1日起首次将GLP-1类减肥药纳入常规报销体系，符合条件的Medicare参保患者可按月自付50美元购得Wegovy，政策利好持续发酵。同日，有报道称诺和诺德正寻求供应商降低原材料价格以维持市场竞争力，显示公司在需求放量的同时积极优化成本结构。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176561117","title":"异动解读｜诺和诺德盘中上涨3.18%，美国联邦医保首次覆盖减肥药利好兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=1176561117","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176561117?lang=zh_cn&edition=full","pubTime":"2026-07-01 22:34","pubTimestamp":1782916499,"startTime":"0","endTime":"0","summary":"7月1日，诺和诺德盘中上涨3.18%，报49.32美元/股，成交额1.6亿美元。消息面上，美国联邦医疗保险自7月1日起首次将GLP-1类减肥药物纳入常规报销体系，诺和诺德同日宣布符合条件的Medicare参保患者现可按月自付50美元购得Wegovy。值得注意的是，诺和诺德逆势走强，同行业礼来跌1.33%、阿斯利康跌2.93%、默沙东跌1.84%，板块整体承压下公司凭借政策直接利好独立走高。此前杰富瑞及高盛亦相继上调诺和诺德目标价，反映市场对其GLP-1商业化前景持续看好。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648651733","title":"诺和诺德：符合条件的联邦医疗保险参保患者现在可按月自付50美元购得Wegovy。","url":"https://stock-news.laohu8.com/highlight/detail?id=2648651733","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648651733?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:01","pubTimestamp":1782903695,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","LU1093756325.SGD","BK4585","IE00BZ1G4Q59.USD","NVOX","BK4007","BK4599","LU1093756168.USD","NVO","LU0154236417.USD","NVOH","IE00BKVL7J92.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647555250","title":"美国联邦医疗保险七月起首次覆盖减肥药物，诺和诺德股价应声上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2647555250","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647555250?lang=zh_cn&edition=full","pubTime":"2026-06-30 20:27","pubTimestamp":1782822420,"startTime":"0","endTime":"0","summary":"美国联邦医疗保险周一宣布，自7月1日起将首次覆盖选择性GLP-1类减肥药物，包括诺和诺德生产的司美格鲁肽注射剂。这意味着数千万Medicare参保人将有机会获得这类广受欢迎的减肥药物的报销资格。受此消息提振，诺和诺德股价在周一交易中上涨约0.6%。　　根据美国医疗保险与医疗补助服务中心发布的最终指南，此次覆盖适用于被诊断为肥胖症的患者，即体重指数达到30或以上的人群。此次政策调整是Medicare成立以来首次将减肥药物纳入常规报销体系。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-30/doc-inifexfq1520001.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0106831901.USD","LU2271345857.HKD","LU0912757837.SGD","LU1074936037.SGD","NVOH","LU0267386448.USD","LU0225283273.USD","LU2357305700.SGD","LU0971096721.USD","LU0210528500.USD","LU0390134368.USD","LU0053666078.USD","BK4588","LU1989772840.SGD","LU2264538146.SGD","LU1244550494.USD","LU2487616109.SGD","NVO","LU1064131342.USD","LU1732799900.SGD","LU0795875169.SGD","BK4504","LU0557290698.USD","BK4532","BK4599","LU1244550221.USD","BK4127","LU1791710582.SGD","BK4516","LU1988902786.USD","LU2133065610.SGD","NVOX","LU1093756325.SGD","LU0006306889.USD","LU1363072403.SGD","LU0320765646.SGD","LU0154236417.USD","LU1668664300.SGD","LU1732800096.USD","BK4007","LU0795875086.SGD","LU0234570918.USD","LU0314104364.USD","LU2347655156.SGD","BK4534","MS","LU1989772923.USD","IE00BZ1G4Q59.USD","LU1791710400.SGD","BK4581","LU2023251221.USD","LU1162221912.USD","LU2028103732.USD","LU0882574139.USD","LU1244550577.SGD","LU2089284900.SGD","IE00BKVL7J92.USD","LU1720051108.HKD","LU1720051017.SGD","LU1093756168.USD","LU0106261372.USD","BK4585","LU0098860793.USD","LU2111349929.HKD","LU0158827781.USD","LU1548497426.USD","LU0528227936.USD","LU2089283258.USD","LU0158827948.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647581242","title":"杰富瑞将诺和诺德目标股价从270丹麦克朗上调至285丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2647581242","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647581242?lang=zh_cn&edition=full","pubTime":"2026-06-30 12:03","pubTimestamp":1782792190,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4599","BK4532","NVOH","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4007","NVO","NVOX","IE00BKVL7J92.USD","LU0154236417.USD","LU1093756325.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646033697","title":"高盛将诺和诺德目标价从305丹麦克朗上调至310丹麦克朗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646033697","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646033697?lang=zh_cn&edition=full","pubTime":"2026-06-26 13:03","pubTimestamp":1782450188,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4588","BK4599","IE00BKVL7J92.USD","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","NVOX","BK4007","NVOH","BK4532","LU1093756325.SGD","BK4585","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646756628","title":"诺和诺德(NVO.US)美国负责人表示Wegovy口服剂型销量中直接面向消费者的销售占比达90%注射剂型该比例为30%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2646756628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646756628?lang=zh_cn&edition=full","pubTime":"2026-06-25 17:03","pubTimestamp":1782378219,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NVOH","LU0154236417.USD","NVOX","BK4007","NVO","IE00BZ1G4Q59.USD","LU1093756168.USD","BK4532","IE00BKVL7J92.USD","BK4585","LU1093756325.SGD","BK4588","BK4599"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novonordisk.com","stockEarnings":[{"period":"1week","weight":0.0342},{"period":"1month","weight":0.1512},{"period":"3month","weight":0.2353},{"period":"6month","weight":-0.1888},{"period":"1year","weight":-0.2478},{"period":"ytd","weight":-0.0063}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0},{"period":"3month","weight":0.0757},{"period":"6month","weight":0.0913},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novo Nordisk A/S成立于1989年，由两家丹麦公司Nordisk Gentofte A/S和Novo Industri A/S合并而成。该公司是一家全球性的医疗保健公司，也是肥胖和糖尿病护理、制造和营销包括GLP-1受体激动剂和现代胰岛素在内的医药产品的世界领先企业。总部位于丹麦，业务遍及约80个国家，产品销往约170个国家。","yearOnYearQuotes":[{"month":1,"riseRate":0.533333,"avgChangeRate":0.120105},{"month":2,"riseRate":0.6,"avgChangeRate":0.019219},{"month":3,"riseRate":0.444444,"avgChangeRate":0.006415},{"month":4,"riseRate":0.622222,"avgChangeRate":0.018023},{"month":5,"riseRate":0.565217,"avgChangeRate":0.019713},{"month":6,"riseRate":0.695652,"avgChangeRate":0.026728},{"month":7,"riseRate":0.5,"avgChangeRate":-0.000467},{"month":8,"riseRate":0.533333,"avgChangeRate":0.006145},{"month":9,"riseRate":0.555556,"avgChangeRate":-0.002979},{"month":10,"riseRate":0.488889,"avgChangeRate":-0.004606},{"month":11,"riseRate":0.6,"avgChangeRate":0.026574},{"month":12,"riseRate":0.733333,"avgChangeRate":0.048757}],"exchange":"NYSE","name":"诺和诺德","nameEN":"Novo-Nordisk A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺和诺德,NVO,诺和诺德股票,诺和诺德股票老虎,诺和诺德股票老虎国际,诺和诺德行情,诺和诺德股票行情,诺和诺德股价,诺和诺德股市,诺和诺德股票价格,诺和诺德股票交易,诺和诺德股票购买,诺和诺德股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺和诺德(NVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺和诺德(NVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}